Efficiency of immunocastration with an anti-gonadotropin-releasing hormone vaccine on cryptorchid bulls
- PMID: 36927961
- PMCID: PMC10209463
- DOI: 10.1292/jvms.22-0571
Efficiency of immunocastration with an anti-gonadotropin-releasing hormone vaccine on cryptorchid bulls
Abstract
Cryptorchid bulls have low economic value owing to the effects of masculinization. Moreover, surgical removal of an ectopic testis is difficult in certain clinical cases. Recently, immunocastration has garnered popularity as a nonsurgical castration method in pig farming; however, the effects of immunocastration on cryptorchid bulls are yet to be yet. Herein, we investigated endocrine changes due to immunocastration in cryptorchid bulls and studied its effectiveness. This study included 13 Holstein bulls diagnosed with cryptorchidism and classified into two groups based on pubertal period: <8 months of age (pregroup) and ≥8 months of age (postgroup). Antigonadotropin-releasing hormone (GnRH) vaccine was used for immunocastration, and two vaccine doses were administered. Blood testosterone and anti-Müllerian hormone (AMH) levels were measured and analyzed for endocrine evaluation. The testosterone levels significantly decreased following the start of immunocastration in both groups, thereby confirming the efficacy of antiGnRH vaccination in cryptorchid bulls. The AMH levels significantly increased in the pregroup with two antiGnRH vaccination, suggesting a compensatory response via the neutralization of GnRH antibodies. The AMH levels did not significantly change in the postgroup, indicating the partial suppression of AMH secretion in Sertoli cells during sexual maturation and failure of Sertoli cell maturation. Thus, we successfully restrained the serum testosterone levels in cryptorchid bulls using antiGnRH vaccine. The testosterone levels are a useful indicator of the immunocastration effect on cryptorchid bulls. Hereafter, a vaccine program that can sustain the castration effect on cryptorchid bulls is necessary.
Keywords: anti-Müllerian hormone; antiGnRH vaccine; bull; cryptorchid; immunocastration.
Conflict of interest statement
The authors declare no conflicts of interest associated with this manuscript.
Figures
Similar articles
-
Cryptorchidism and the pituitary--testicular axis in bulls.J Reprod Fertil Suppl. 1981;30:67-73. J Reprod Fertil Suppl. 1981. PMID: 6132006
-
Effect of unilateral castration and unilateral cryptorchidism on gonadotropin and testosterone response to gonadotropin releasing hormone in the bull.J Anim Sci. 1981 Nov;53(5):1341-50. doi: 10.2527/jas1981.5351341x. J Anim Sci. 1981. PMID: 6119304
-
Expression of anti-Müllerian hormone, CDKN1B, connexin 43, androgen receptor and steroidogenic enzymes in the equine cryptorchid testis.Equine Vet J. 2013 Sep;45(5):538-45. doi: 10.1111/evj.12013. Epub 2013 Jan 7. Equine Vet J. 2013. PMID: 23294085
-
New trends in immunocastration and its potential to improve animal welfare: a mini review.Trop Anim Health Prod. 2022 Nov 2;54(6):369. doi: 10.1007/s11250-022-03348-8. Trop Anim Health Prod. 2022. PMID: 36323906 Review.
-
Hormonal Aspects of the Pathogenesis and Treatment of Cryptorchidism.Eur J Pediatr Surg. 2016 Oct;26(5):409-417. doi: 10.1055/s-0036-1592415. Epub 2016 Sep 19. Eur J Pediatr Surg. 2016. PMID: 27642852 Review.
Cited by
-
Caveolin 1 Regulates the Tight Junctions between Sertoli Cells and Promotes the Integrity of Blood-Testis Barrier in Yak via the FAK/ERK Signaling Pathway.Animals (Basel). 2024 Jan 5;14(2):183. doi: 10.3390/ani14020183. Animals (Basel). 2024. PMID: 38254351 Free PMC article.
-
GnRH-immunocastration: an alternative method for male animal surgical castration.Front Vet Sci. 2023 Oct 31;10:1248879. doi: 10.3389/fvets.2023.1248879. eCollection 2023. Front Vet Sci. 2023. PMID: 38026623 Free PMC article. Review.
References
-
- Aksglaede L, Sørensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, Petersen JH, Linneberg A, Andersson AM, Main KM, Skakkebæk NE, Juul A. 2010. Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 95: 5357–5364. doi: 10.1210/jc.2010-1207 - DOI - PubMed